カテゴリ： Market Monitor Global, 世界, 医療/バイオ

バセドウ病治療のグローバル市場展望 2023年-2029年：抗甲状腺薬、放射性ヨウ素療法

■ 英語タイトル：Graves Disease Treatment Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5597）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5597
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：74
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[バセドウ病治療のグローバル市場展望 2023年-2029年：抗甲状腺薬、放射性ヨウ素療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のバセドウ病治療市場規模と予測を収録しています。・世界のバセドウ病治療市場：売上、2018年-2023年、2024年-2029年
・世界のバセドウ病治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバセドウ病治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗甲状腺薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

バセドウ病治療のグローバル主要企業は、Abbott、 GlaxoSmithKline plc、 Merck & Co、 Pfizer, Inc、 RLC LABS、 AbbVie, Inc、 Mylan N.V、 Allergan, plc、 Novartis AG、 Apitope、 Amgen INC.、 Sun Pharmaceuticals Industries LTD、 Immunovant Incなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、バセドウ病治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のバセドウ病治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のバセドウ病治療市場：タイプ別市場シェア、2022年
・抗甲状腺薬、放射性ヨウ素療法

世界のバセドウ病治療市場：用途別、2018年-2023年、2024年-2029年
世界のバセドウ病治療市場：用途別市場シェア、2022年
・病院薬局、小売薬局

世界のバセドウ病治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のバセドウ病治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるバセドウ病治療のグローバル売上、2018年-2023年
・主要企業におけるバセドウ病治療のグローバル売上シェア、2022年
・主要企業におけるバセドウ病治療のグローバル販売量、2018年-2023年
・主要企業におけるバセドウ病治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Abbott、 GlaxoSmithKline plc、 Merck & Co、 Pfizer, Inc、 RLC LABS、 AbbVie, Inc、 Mylan N.V、 Allergan, plc、 Novartis AG、 Apitope、 Amgen INC.、 Sun Pharmaceuticals Industries LTD、 Immunovant Inc

*************************************************************

・調査・分析レポートの概要
バセドウ病治療市場の定義
市場セグメント
世界のバセドウ病治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバセドウ病治療市場規模
世界のバセドウ病治療市場規模：2022年 VS 2029年
世界のバセドウ病治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバセドウ病治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバセドウ病治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗甲状腺薬、放射性ヨウ素療法
バセドウ病治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局
バセドウ病治療の用途別グローバル売上・予測

・地域別市場分析
地域別バセドウ病治療市場規模 2022年と2029年
地域別バセドウ病治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Abbott、 GlaxoSmithKline plc、 Merck & Co、 Pfizer, Inc、 RLC LABS、 AbbVie, Inc、 Mylan N.V、 Allergan, plc、 Novartis AG、 Apitope、 Amgen INC.、 Sun Pharmaceuticals Industries LTD、 Immunovant Inc
...

Graves’ disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves’ disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves’ disease can be wide ranging.
This report aims to provide a comprehensive presentation of the global market for Graves Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Graves Disease Treatment. This report contains market size and forecasts of Graves Disease Treatment in global, including the following market information:
Global Graves Disease Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Graves Disease Treatment Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Graves Disease Treatment companies in 2022 (%)
The global Graves Disease Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anti-Thyroid Medication Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Graves Disease Treatment include Abbott, GlaxoSmithKline plc, Merck & Co, Pfizer, Inc, RLC LABS, AbbVie, Inc, Mylan N.V, Allergan, plc and Novartis AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Graves Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Graves Disease Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Type, 2022 (%)
Anti-Thyroid Medication
Radioactive Iodine Therapy
Global Graves Disease Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacies
Retail Pharmacies
Global Graves Disease Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Graves Disease Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Graves Disease Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Graves Disease Treatment revenues share in global market, 2022 (%)
Key companies Graves Disease Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Graves Disease Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
GlaxoSmithKline plc
Merck & Co
Pfizer, Inc
RLC LABS
AbbVie, Inc
Mylan N.V
Allergan, plc
Novartis AG
Apitope
Amgen INC.
Sun Pharmaceuticals Industries LTD
Immunovant Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Graves Disease Treatment, market overview.
Chapter 2: Global Graves Disease Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Graves Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Graves Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Graves Disease Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Graves Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Graves Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Graves Disease Treatment Overall Market Size
2.1 Global Graves Disease Treatment Market Size: 2022 VS 2029
2.2 Global Graves Disease Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Graves Disease Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Graves Disease Treatment Players in Global Market
3.2 Top Global Graves Disease Treatment Companies Ranked by Revenue
3.3 Global Graves Disease Treatment Revenue by Companies
3.4 Global Graves Disease Treatment Sales by Companies
3.5 Global Graves Disease Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Graves Disease Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Graves Disease Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Graves Disease Treatment Players in Global Market
3.8.1 List of Global Tier 1 Graves Disease Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Graves Disease Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Graves Disease Treatment Market Size Markets, 2022 & 2029
4.1.2 Anti-Thyroid Medication
4.1.3 Radioactive Iodine Therapy
4.2 By Type – Global Graves Disease Treatment Revenue & Forecasts
4.2.1 By Type – Global Graves Disease Treatment Revenue, 2018-2023
4.2.2 By Type – Global Graves Disease Treatment Revenue, 2024-2029
4.2.3 By Type – Global Graves Disease Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Graves Disease Treatment Sales & Forecasts
4.3.1 By Type – Global Graves Disease Treatment Sales, 2018-2023
4.3.2 By Type – Global Graves Disease Treatment Sales, 2024-2029
4.3.3 By Type – Global Graves Disease Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Graves Disease Treatment Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application – Global Graves Disease Treatment Revenue & Forecasts
5.2.1 By Application – Global Graves Disease Treatment Revenue, 2018-2023
5.2.2 By Application – Global Graves Disease Treatment Revenue, 2024-2029
5.2.3 By Application – Global Graves Disease Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Graves Disease Treatment Sales & Forecasts
5.3.1 By Application – Global Graves Disease Treatment Sales, 2018-2023
5.3.2 By Application – Global Graves Disease Treatment Sales, 2024-2029
5.3.3 By Application – Global Graves Disease Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Graves Disease Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Graves Disease Treatment Market Size, 2022 & 2029
6.2 By Region – Global Graves Disease Treatment Revenue & Forecasts
6.2.1 By Region – Global Graves Disease Treatment Revenue, 2018-2023
6.2.2 By Region – Global Graves Disease Treatment Revenue, 2024-2029
6.2.3 By Region – Global Graves Disease Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Graves Disease Treatment Sales & Forecasts
6.3.1 By Region – Global Graves Disease Treatment Sales, 2018-2023
6.3.2 By Region – Global Graves Disease Treatment Sales, 2024-2029
6.3.3 By Region – Global Graves Disease Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Graves Disease Treatment Revenue, 2018-2029
6.4.2 By Country – North America Graves Disease Treatment Sales, 2018-2029
6.4.3 US Graves Disease Treatment Market Size, 2018-2029
6.4.4 Canada Graves Disease Treatment Market Size, 2018-2029
6.4.5 Mexico Graves Disease Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Graves Disease Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Graves Disease Treatment Sales, 2018-2029
6.5.3 Germany Graves Disease Treatment Market Size, 2018-2029
6.5.4 France Graves Disease Treatment Market Size, 2018-2029
6.5.5 U.K. Graves Disease Treatment Market Size, 2018-2029
6.5.6 Italy Graves Disease Treatment Market Size, 2018-2029
6.5.7 Russia Graves Disease Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Graves Disease Treatment Market Size, 2018-2029
6.5.9 Benelux Graves Disease Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Graves Disease Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Graves Disease Treatment Sales, 2018-2029
6.6.3 China Graves Disease Treatment Market Size, 2018-2029
6.6.4 Japan Graves Disease Treatment Market Size, 2018-2029
6.6.5 South Korea Graves Disease Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Graves Disease Treatment Market Size, 2018-2029
6.6.7 India Graves Disease Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Graves Disease Treatment Revenue, 2018-2029
6.7.2 By Country – South America Graves Disease Treatment Sales, 2018-2029
6.7.3 Brazil Graves Disease Treatment Market Size, 2018-2029
6.7.4 Argentina Graves Disease Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Graves Disease Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Graves Disease Treatment Sales, 2018-2029
6.8.3 Turkey Graves Disease Treatment Market Size, 2018-2029
6.8.4 Israel Graves Disease Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Graves Disease Treatment Market Size, 2018-2029
6.8.6 UAE Graves Disease Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Graves Disease Treatment Major Product Offerings
7.1.4 Abbott Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Company Summary
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Graves Disease Treatment Major Product Offerings
7.2.4 GlaxoSmithKline plc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.2.5 GlaxoSmithKline plc Key News & Latest Developments
7.3 Merck & Co
7.3.1 Merck & Co Company Summary
7.3.2 Merck & Co Business Overview
7.3.3 Merck & Co Graves Disease Treatment Major Product Offerings
7.3.4 Merck & Co Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Merck & Co Key News & Latest Developments
7.4 Pfizer, Inc
7.4.1 Pfizer, Inc Company Summary
7.4.2 Pfizer, Inc Business Overview
7.4.3 Pfizer, Inc Graves Disease Treatment Major Product Offerings
7.4.4 Pfizer, Inc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer, Inc Key News & Latest Developments
7.5 RLC LABS
7.5.1 RLC LABS Company Summary
7.5.2 RLC LABS Business Overview
7.5.3 RLC LABS Graves Disease Treatment Major Product Offerings
7.5.4 RLC LABS Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.5.5 RLC LABS Key News & Latest Developments
7.6 AbbVie, Inc
7.6.1 AbbVie, Inc Company Summary
7.6.2 AbbVie, Inc Business Overview
7.6.3 AbbVie, Inc Graves Disease Treatment Major Product Offerings
7.6.4 AbbVie, Inc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.6.5 AbbVie, Inc Key News & Latest Developments
7.7 Mylan N.V
7.7.1 Mylan N.V Company Summary
7.7.2 Mylan N.V Business Overview
7.7.3 Mylan N.V Graves Disease Treatment Major Product Offerings
7.7.4 Mylan N.V Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Mylan N.V Key News & Latest Developments
7.8 Allergan, plc
7.8.1 Allergan, plc Company Summary
7.8.2 Allergan, plc Business Overview
7.8.3 Allergan, plc Graves Disease Treatment Major Product Offerings
7.8.4 Allergan, plc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.8.5 Allergan, plc Key News & Latest Developments
7.9 Novartis AG
7.9.1 Novartis AG Company Summary
7.9.2 Novartis AG Business Overview
7.9.3 Novartis AG Graves Disease Treatment Major Product Offerings
7.9.4 Novartis AG Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.9.5 Novartis AG Key News & Latest Developments
7.10 Apitope
7.10.1 Apitope Company Summary
7.10.2 Apitope Business Overview
7.10.3 Apitope Graves Disease Treatment Major Product Offerings
7.10.4 Apitope Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.10.5 Apitope Key News & Latest Developments
7.11 Amgen INC.
7.11.1 Amgen INC. Company Summary
7.11.2 Amgen INC. Graves Disease Treatment Business Overview
7.11.3 Amgen INC. Graves Disease Treatment Major Product Offerings
7.11.4 Amgen INC. Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.11.5 Amgen INC. Key News & Latest Developments
7.12 Sun Pharmaceuticals Industries LTD
7.12.1 Sun Pharmaceuticals Industries LTD Company Summary
7.12.2 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Business Overview
7.12.3 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Major Product Offerings
7.12.4 Sun Pharmaceuticals Industries LTD Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.12.5 Sun Pharmaceuticals Industries LTD Key News & Latest Developments
7.13 Immunovant Inc
7.13.1 Immunovant Inc Company Summary
7.13.2 Immunovant Inc Graves Disease Treatment Business Overview
7.13.3 Immunovant Inc Graves Disease Treatment Major Product Offerings
7.13.4 Immunovant Inc Graves Disease Treatment Sales and Revenue in Global (2018-2023)
7.13.5 Immunovant Inc Key News & Latest Developments
8 Global Graves Disease Treatment Production Capacity, Analysis
8.1 Global Graves Disease Treatment Production Capacity, 2018-2029
8.2 Graves Disease Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Graves Disease Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Graves Disease Treatment Supply Chain Analysis
10.1 Graves Disease Treatment Industry Value Chain
10.2 Graves Disease Treatment Upstream Market
10.3 Graves Disease Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Graves Disease Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 胃食道逆流症治療薬＆装置のグローバル市場展望 2023年-2029年：医薬品、機器
  • 神経疾患治療薬のグローバル市場展望 2023年-2029年：抗コリン薬、抗てんかん薬、抗精神病薬、催眠鎮静薬、鎮痛薬、降圧薬、抗凝固薬、その他
  • パーキンソン病治療薬のグローバル市場展望 2023年-2029年：臨床、実験
  • ブルーアイ症候群ワクチンのグローバル市場展望 2023年-2029年：生ワクチン、死菌ワクチン
  • 代謝疾患治療薬のグローバル市場展望 2023年-2029年：グリコーゲン代謝疾患治療薬、脂質代謝疾患治療薬、アミノ酸代謝疾患治療薬、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5597 )"バセドウ病治療のグローバル市場展望 2023年-2029年：抗甲状腺薬、放射性ヨウ素療法" (英文：Graves Disease Treatment Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。